Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInsig Ai Plc Regulatory News (INSG)

Share Price Information for Insig Ai Plc (INSG)

Share Price is delayed by 15 minutes
Get Live Data
14.00    0.00 (0.00%)
Bid:
13.50
Ask:
14.50
Spread: 1.00 (7.407%)
Market Cap: £17.67m
INSG Live PriceLast checked at - London Stock Exchange

Intraday Insig Ai Plc Share Chart

New Contract Win

7 Nov 2022 07:00

RNS Number : 4542F
Insig AI Plc
07 November 2022
Β 

7 November 2022Β 

Β 

Insig AI plc

("Insig AI", the "Company" or the "Group")

Contract Win

Insig AI plc (AIM:INSG), the data science and machine learning solutions company serving the asset management industry, is pleased to announce that a London based alternative investment manager with in excess of $1 billion of assets under management has signed a consultancy agreement that will draw on Insig AI's fintech data science capabilities with the aim of generating alpha.

The contract value is GBP120,000 and is expected to be completed by 31 December 2022. The Company is in active discussions with other institutions.

Colm McVeigh, Insig AI's Chief Executive commented: "It is encouraging to see our customers investing as they look to exploit opportunities in the current dynamic market. We see a strong business case for other progressive asset managers to work with us to add value to their businesses."

Β 

Β 

Β 

For further information, please visitΒ www.insg.aiΒ or contact: Β 

Insig AI plc

Colm McVeigh (CEO)

Β 

Β 

ZeusΒ (Nominated Adviser & Broker)

David ForemanΒ /Β James HornigoldΒ /Β Danny Phillips

+44 (0) 20 3829 5000

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
CNTUPGRUGUPPPGQ
Date   Source Headline
8th Nov 20227:00 amRNSDirector/PDMR Shareholding
7th Nov 20227:00 amRNSNew Contract Win
3rd Nov 20227:00 amRNSTrading update
26th Oct 20227:00 amRNSConvertible Loan Facility drawdown
17th Oct 20227:00 amRNSPartnership agreement with BRAIN
12th Oct 20227:00 amRNSConvertible Loan Facility Agreement and drawdown
30th Sep 202212:13 pmRNSResult of Annual General Meeting & General Meeting
30th Sep 20227:00 amRNSContract win
26th Sep 20227:00 amRNSConvertible Loan Facility drawdown
20th Sep 20227:00 amRNSChange of Registered Office
12th Sep 20227:00 amRNSConvertible Loan Facility Agreement
9th Sep 20227:00 amRNSFinal Results, Posting of Report and Notice of GM
8th Sep 20227:00 amRNSNotice of AGM
30th Aug 20227:00 amRNSConvertible Loan Facility Agreement and Drawdown
2nd Aug 20227:00 amRNSDirector/PDMR Shareholding
29th Jul 20227:00 amRNSDirector/PDMR Shareholding
26th Jul 20227:00 amRNSConvertible Loan Facility Agreement drawdown
19th Jul 20227:00 amRNSDirectors' Disclosure
6th Jul 20227:00 amRNSDirector/PDMR Shareholding
1st Jul 20227:00 amRNSDirector/PDMR Shareholding
17th Jun 202210:30 amRNSConvertible loan agreement and drawdown
31st May 20227:00 amRNSData partnership and research agreement
5th May 20227:00 amRNSData share partnership agreement with Snowflake
4th May 20227:00 amRNSConvertible Loan Facility Agreement and drawdown
28th Apr 20227:00 amRNSUpdate on agreement with CarVal Investors, L.P
26th Apr 20227:00 amRNSDirector/PDMR Shareholding
25th Apr 20227:00 amRNSContract win, trading update and Board changes
11th Apr 20227:00 amRNSDirectorate Change
24th Mar 20227:00 amRNSDirector/PDMR Shareholding
22nd Mar 20227:00 amRNSDirector/PDMR Shareholding
21st Mar 20227:00 amRNSTrading and operations update
25th Feb 20227:00 amRNSFurther agreement with CarVal Investors, L.P.
7th Feb 20227:00 amRNSInsig AI selected for PwC Scale FinTech programme
14th Jan 20227:00 amRNSDirector/PDMR Shareholding
6th Jan 20221:41 pmRNSDirector/PDMR Shareholding
30th Dec 20217:00 amRNSDirectorate change
23rd Dec 202112:55 pmRNSDirector/PDMR Shareholding
23rd Dec 20218:42 amRNSDirector/PDMR Shareholding
22nd Dec 20217:00 amRNSInterim Results
13th Dec 20217:00 amRNSContract win
10th Dec 20217:00 amRNSColm McVeigh appointment to the Board
19th Nov 202111:36 amRNSDirector/PDMR Shareholding
19th Nov 20217:00 amRNSDirector/PDMR Shareholding
18th Nov 20217:00 amRNSAcquisition of FDB Systems Limited
15th Nov 20217:00 amRNSProof of concept signed with asset manager
10th Nov 20217:00 amRNSESG scoring solution delivered to CarVal Investors
10th Nov 20217:00 amRNSColm McVeigh appointed as Chief Commercial Officer
4th Nov 20217:00 amRNSInvestor Presentation
1st Nov 20217:00 amRNSInsig AI Becomes a Sponsor of the UK's APPG on ESG
4th Oct 20217:00 amRNSRelease of Insig Portfolio 2.0

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.